Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review

Author:

Konstas Anastasios G.1,Schmetterer Leopold2,Costa Vital P.3,Holló Gábor4ORCID,Katsanos Andreas5ORCID,Denis Philippe6,Quaranta Luciano7,Irkec Murat8,Castejón Miguel A.9,Teus Miguel A.10,Robin Alan L.11

Affiliation:

1. 1st and 3rd University Departments of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece

2. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore; Academic Clinical Program, Duke-NUS Medical School, Singapore; SERI-NTU Advanced Ocular Engineering (STANCE), Singapore; Department of Clinical Pharmacology, Medical University of Vienna, Austria; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Austria; Institute of Clinical and Molecular Ophthalmology,...

3. Department of Ophthalmology, Universidade Estadual De Campinas, Campinas, Brazil

4. Department of Ophthalmology, Semmelweis University, Budapest, Hungary

5. Department of Ophthalmology, University of Ioannina, Ioannina, Greece

6. Department of Ophthalmology, Croix-Rousse University Hospital, Lyon, France

7. Department of Surgical & Clinical, Diagnostic and Pediatric Sciences, Section of Ophthalmology, University of Pavia-IRCCS Fondazione Policlinico San Matteo, Pavia, Italy

8. Department of Ophthalmology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

9. Ophthalmology Department, University Hospital “Príncipe De Asturias”, Alcalá De Henares, Spain

10. Ophthalmology Department, University of Alcala, Madrid, Spain

11. Wilmer Eye Institute and Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland, USA; Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA

Funder

No funding or sponsorship

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3